RT Journal Article
SR Electronic
A1 Jacobson, Anne
T1 Candesartan Slows the Onset of Retinopathy in Patients with Type 1 Diabetes
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 7
SP 14
OP 15
DO 10.1177/155989770800800706
UL http://mdc.sagepub.com/content/8/7/14.abstract
AB Treatment with an angiotensin-II receptor blocker may slow the development of retinopathy among patients with type 1 diabetes, according to findings from the Diabetic Retinopathy Candesartan Trials [DIRECT] Study Programme. Although the primary endpoint was not met, secondary findings suggest that inhibition of the renin-angiotensin system may lessen the risk of microvascular complications in this patient population.